Ursheet Parikh, partner at Mayfield and investor in Mammoth Biosciences, traces the evolution of life sciences tech companies that led to the trend of startups focused on creating assets for large pharmaceutical companies to buy. He describes how Mammoth, in contrast, built a platform-based company from the start, guided by their mission to impact and save as many lives as possible.
Related
![Photo of Alexandra Zatarain](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/05/Alexandra-Zatarain-600x600-1.png)
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Video
50 minutes
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
![Photo of Maria Barrera](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/04/Maria-Barrera-600x600-.png)
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Video
49 minutes
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
![Photo of David Allemann](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/03/David-Allemann-600x600-2.png)
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
Video
50 minutes
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.